logo
Home > Task Forces > Technology Platforms >

Technology Platforms Task Force

Task Force group leader: Prof. Dr. Ron Wevers

IGMD research and patient care relies to a large extent on an excellent technical infrastructure built around a core of state of the art technology platforms (sequencing facility, genome scanning, ex-pression array, proteomics facility, metabolomics and glycomics facility). These platforms are the building blocks to successfully apply genomics, proteomics and metabolomics approaches and bring the data together in a holistic systems biology approach to genetic and metabolic disease. For researchers it is a challenge to make use of these facilities in their work and to incorporate this high tech infrastructure in future grant applications.

Sequencing facility:  
Dr. H. Scheffer

Next generation sequencing:  
Dr. J. Veltman

Expression and genomic arrays: 
Dr. J. Veltman

Proteomics facility: 
Dr. L.P. van de Heuvel

Metabolomics:                                       
Dr. L. Kluijtmans        

Glycomics:                     
                          
Dr. D. Lefeber